Notizie dei mercati

CASI Pharmaceuticals, Inc.: HC Wainwright conferma il rating Buy

This content has been archived. It may no longer be relevant

CASI Pharmaceuticals, Inc.: HC Wainwright conferma il rating Buy

Pharmaceuticals Wainwright conferma


FIMA2681# 2022-08-15T17:01:15+02:00

Show More